Podcasts about AML

The AI Recruiting Summit 2026 is happening now through July 20th, and registration is free for every live session. Recruiting engineers, operators, and recruiters actually running AI on their desks are showing what is working behind the scenes. Do not miss it. Register here: https://ai-recruiting-summit-2026.heysummit.com/ This episode is brought to you by Atlas. The resume never tells the full story, and most of what candidates share ends up buried in notes and forgotten. Atlas is the AI first recruitment platform built to eliminate admin. It captures every conversation automatically, and with MagicSearch you can ask things like who mentioned they are open to relocating and pull the answer from your entire database instantly. Atlas customers have reported over 40% EBITDA growth and over 80% increase in monthly billings after adopting the platform. Unlock your exclusive listener offer here: https://recruitwithatlas.com/ Holly Dary spent nearly 20 years becoming everything she set out to be at a large global staffing firm. She oversaw eight markets, built teams that produced, and made very good money. Then she hit her 20 year mark and a question she could not shake. Keep doing the same thing on repeat until retirement, or bet on herself and build something of her own. She chose the second act. At the end of 2019 she launched Tarbos Talent in Austin, put all of her chips in the middle of the table as the sole provider for her family, and started making placements right away. Then, three months in, COVID shut everything down. Every job order died. Offers were rescinded. For a brand new firm with a database built from nothing, it should have been the end. Instead she doubled down. While competitors furloughed and let go of long time producers, Holly hired the best of them. She built her tech stack and her database through the quiet months, got her team back in the office the moment Texas allowed it, and came out of the shutdown twice as strong. From zero she has built a team of 26 across two offices in Austin and Houston, in a business where most firms take 12 to 18 months just to turn a profit. Tarbos was profitable inside of two. None of that is the most remarkable thing she has survived. Fifteen years ago, when her daughter had just turned one, Holly was diagnosed with AML leukemia and told to get to the hospital within 30 minutes. She was not scared. She was furious that anything might take her from her kids, and she carried the same positive mindset that runs her business straight through treatment. Her oncologist later told her that her attitude was half the reason she made it. In this conversation Holly breaks down how she builds firms that win. Why the human touch is what separates an elite recruiter from a replaceable one. Why she recruits like a sniper instead of blasting 500 people at once. Why speed and sitting shoulder to shoulder with her team is a real advantage in a remote world. And why, after 26 years, doing the reps is still the whole game. If there is a quiet voice in the back of your head telling you it is time for your own second act, this is the episode. Connect with Holly Dary on LinkedIn: https://www.linkedin.com/in/holly-dary-aba2952/ Listen to the full episode:

No one said building a regulator from the ground up would be easy.But when the organisation chair, Bruna Szego, describes it as like ‘flying a plane while building it' – you have to wonder how things are going on the ground. Our expert host, Robin Lycka, is joined by Carlo Boffa, EU Correspondent for AML Intelligence, to ask: Is AMLA really on track? The panel discuss: what AMLA looks like from Frankfurt, whether cracks are starting to show, and what compliance teams should expect by July 2027.Producer: Matthew Dunne-MilesEditor: Dominic DelargyVideo: Loïs DunfordCheck out our new short-film Yes, Chef! here. Subscribe to our newsletter, Fresh Laundry, here.____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.ai Hosted on Acast. See acast.com/privacy for more information.

What's up fraud fighters, and welcome back to Fraud Forward!Over the last few months, I've had more conversations about agentic payments than just about any other topic. At conferences, on webinars, and in discussions with some of the smartest people in payments, compliance, and fraud, one thing has become clear to me: I think we're asking the wrong question.Most people want to know whether AI will start moving money.The question I keep coming back to is this: How do fraud teams investigate transactions when software starts making decisions?In this solo episode, I pull together insights from recent conversations with Matt Vega, Mary Ann Miller, and Matt Janiga to explore what agentic commerce really means for fraud investigations, SAR reporting, and the future of financial crime investigations. We talk about why traditional fraud models have always assumed a human initiated the payment, why that assumption no longer holds, and what investigators will need to understand when AI agents begin making decisions on behalf of customers.The technology may be changing, but the principles of good fraud prevention are not. Documentation, audit trails, authority management, explainability, and strong transaction monitoring will become even more important as agentic payments move from theory to reality.What you'll hear in this episode:Why agentic payments are fundamentally different from traditional payment automation.How agentic commerce changes the way fraud teams investigate payment fraud.Why audit trails, attribution, and explainability will become essential during fraud investigations.How SAR reporting and AML investigations may evolve as AI becomes part of the payment decision process.Why regulators are focused on enabling innovation safely instead of slowing it down.The three questions every fraud investigator should begin asking today to prepare for the future.You should listen to this episode if you:Work in fraud prevention, AML compliance, investigations, or financial crime.File suspicious activity reports or conduct SAR reporting.Lead fraud operations, transaction monitoring, or payment investigations.Are evaluating how AI and agentic commerce will affect your institution.Want practical steps your team can begin implementing today instead of waiting for the rulebook to catch up.

Welcome back to the Fintech Takes podcast. I'm your host, Alex Johnson, and today one of our favorite guests is back: Frank Rotman, founding partner of 37Maru and co-founder and partner emeritus at QED Investors. First, we chat about what happens to an entire industry once its customers have concluded the game is rigged, which is why financial nihilism now shows up everywhere from ETFs built on sports bets to DeFi products costumed as savings accounts. Frank has a theory he calls p(win)=0; once someone concludes their probability of winning is zero, walking away from the game is rational.  From there, we separate the AI use cases ready for prime time from the ones that aren't. Back office work like AML documentation and exception processing is ripe for automation. A bank chatbot delivering flawless, compliant financial advice is a different proposition. In financial services, 98% accuracy can still equal zero. Finally, we close on student lending, an area where Frank has firsthand experience (having built a student lending company before QED), and firsthand ideas (having spent the better part of a year making the case for reform to the Department of Education and the IRS). His proposal for how the government could build a “truth file" on which degrees pay off is one of the more concrete policy ideas we discuss. Expect a wide-ranging conversation. Frank has a gift for making financial nihilism, AI, and student loan policy sound like one continuous argument, and by the end, I'm convinced that it is. --- This episode is brought to you by Ocrolus.  Every small business is different — but most lenders only see a snapshot. Ocrolus gives SMB lenders the cash flow analytics, borrower behavior and peer context to fund more, faster, with confidence. Visit ⁠https://www.ocrolus.com/⁠ for more.  --- Sign up for Alex's Fintech Takes newsletter for the latest insightful analysis on fintech trends, along with a heaping pile of pop culture references and copious footnotes. Every Monday and Thursday:⁠ https://workweek.com/brand/fintech-takes/⁠ And for more exclusive insider content, don't forget to check out my⁠ YouTube page⁠. --- Follow Frank: LinkedIn: ⁠https://www.linkedin.com/in/frank-rotman/⁠ X: ⁠https://x.com/fintechjunkie⁠   Follow Alex:  YouTube: ⁠https://www.youtube.com/@FintechTakes⁠ LinkedIn:⁠ https://www.linkedin.com/in/alexhjohnson⁠ X:⁠ https://www.twitter.com/AlexH_Johnson⁠

At just 16 years old, Hayden Laufgraven heard the words no teenager expects:"You have leukemia."What followed was hospitalisation, chemotherapy, a bone marrow transplant, remission, relapse, another transplant, months of isolation, and learning how to never give up. In this deeply moving episode of Talking Smack 415, Jamie the Great and I sit down with Hayden to talk about what it's really like to be diagnosed with Acute Myeloid Leukemia (AML) as a teenager, the emotional toll of the diagnosis and surviving cancer, and the often-overlooked reality of PTSD after cancer treatment.Hayden shares his remarkable perspective on resilience, friendship, identity, and why surviving cancer doesn't mean the journey is over.Whether you've experienced cancer yourself, love someone who has, or simply need a reminder of the strength of the human spirit, this conversation will stay with you long after it ends. Hayden is wise beyond his years. In this episode we discuss:What it's like being diagnosed with Acute Myeloid Leukemia (AML) at age 16The signs and symptoms that led to his leukemia diagnosisChemotherapy, remission, relapse, and undergoing two bone marrow transplantsHow donor registries and bone marrow matching workThe physical and emotional impact of cancer treatmentPTSD and trauma after surviving cancerRebuilding strength after months of chemotherapy and isolationThe importance of friendship, family, and community during illnessMental resilience and finding hope through uncertaintyLife after cancer and returning to college, sports, and everyday lifeHayden's honesty, maturity, and optimism offer an extraordinary reminder that resilience isn't about pretending you're fearless—it's about continuing to move forward anyway.Follow Hayden on TikTok: @haydenlaufIf this episode resonates with you...Please subscribe, rate, and review Talking Smack 415. Sharing this episode may help someone navigating cancer, supporting a loved one through treatment, or healing from the invisible emotional scars that often remain after remission.Cancer changes lives—but so does hope.Share this episode with your friends and family who love to laugh.  Subscribe to Talking Smack 415 and leave us a rating and review so more peeps can find us for laughter and friendship to feed your soul!  

From 1 July, one compliance mistake could cost real estate agencies millions. The problem? Many still don't realise the new rules apply to them. On the REB Business Empowerment Showcase podcast, Liam Garman sits down with Visibl co-founder Kaan Yüksel to break down the new anti-money laundering (AML) laws now reshaping Australian real estate and why every agency needs to act before regulators come knocking. The pair explain how Tranche 2 reforms extend AML obligations to selling agents, principals, directors, and buyer's agents, with agencies now required to verify the identities of both buyers and sellers as part of every transaction. The discussion explores why real estate has become a key target for money laundering, the costly compliance mistakes agencies are most likely to make, and how technology is helping businesses manage the growing administrative burden. Finally, Garman and Yüksel warn that with penalties of up to $33 million per breach, AML compliance is no longer just another box to tick – it's becoming one of the biggest operational risks facing Australian real estate businesses.

Welcome back to the Oncology Brothers podcast! In this episode, we dived into the latest highlights from the EHA 2026 conference, focusing on groundbreaking studies in the leukemia space. Join us as we welcome Dr. Eunice Wang from Roswell Park Comprehensive Cancer Center to discuss three pivotal studies: OPTI-AML: explored the findings on the use of venetoclax in combination with azacitidine for newly diagnosed AML patients, comparing 14-day versus 28-day treatment regimens and their impact on cytopenias and overall outcomes. KOMET-007: promising early data on menin inhibitors, specifically Ziftomenib, in frontline settings for patients with NPM1 and KMT2A rearrangements, and how it may change the landscape of AML treatment. SENTRY: analyzed the combination of ruxolitinib and selinexor for myelofibrosis, discussing its effects on spleen volume reduction and overall survival, as well as the implications of side effects. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o  Follow us on social media: •⁠  ⁠X/Twitter: https://x.com/oncbrothers  •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers  •⁠  Website: https://oncbrothers.com/  Tune in for an insightful discussion on the future of leukemia treatment and the importance of genetic markers in therapy decisions. Don't forget to like, subscribe, and check out our other conference highlights from ASCO and EHA! #EHA2026, #Leukemia, #AML, #Myelofibrosis, #OncologyBrothers  

Rick sits down with Erai Beckmann to talk about the part of blockchain most people either hype up or completely misunderstand. Digital currency sounds like freedom. Until the money disappears and there is nobody to call.In this conversation Erai Beckmann, who has built in regulated industries and is now working on blockchain infrastructure with governments, breaks down why the future of digital currency may not belong to the loudest crypto projects. It may belong to the ones building safety, regulation, identity, auditing, and trust before the public ever hears their name.This episode gets into crypto scams, blockchain regulation, stablecoins, KYC, AML, privacy, digital wallets, global trade, and why the next version of money may look less like speculation and more like infrastructure. The uncomfortable part is simple. If you would not trust the system with your parents life savings, maybe it is not ready yet.In this interview you'll learn:Why blockchain and crypto are not the same thingWhy fully decentralized money sounds powerful until something goes wrongHow regulation could make digital currency safer instead of killing itWhy the future of blockchain may look more like banking infrastructure than internet gamblingHow digital wallets could change global trade, payments, and access to moneyFollow Rick's Socials:Instagram | LinkedIn | RickJordan.TVKeywords: digital currency, blockchain, crypto, cryptocurrency, stablecoins, blockchain regulation, crypto regulation, digital assets, web3, decentralized finance, defi, kyc, aml, money laundering, crypto scams, crypto hacks, ransomware, digital wallet, financial technology, fintech, stablecoin regulation, genius act, clarity act, cbdc, tokenization, real world assets, blockchain security, financial freedom, banking system, swift system, global payments, future of money, crypto safety, digital money, financial privacy, blockchain trust, peace through trade, e-rai beckmann, rick jordan, frequency podcast

What does it actually take to wind down a crypto exchange responsibly?Following the withdrawal of Kriptomat's MiCA application, Delphine Forma speaks with Dejan Davidovič about one of the least discussed areas of crypto compliance: how to close a regulated business while continuing to protect customers and meet regulatory expectations.Together they explore how Kriptomat designed its wind-down strategy, communicated transparently with customers, selected Kraken as its migration partner, managed dormant accounts and asset delistings, and continued meeting its AML and reporting obligations long after trading had stopped.They also discuss the regulatory uncertainty surrounding firms caught between legacy licensing regimes and MiCA, why clear regulatory guidance on wind-downs is still missing, and the lessons every compliance officer, founder and policymaker should take from the first generation of MiCA applications.Whether you're preparing for authorisation, managing regulatory change or simply interested in the realities of running a regulated crypto business, this episode offers practical insights rarely shared in public.

The illegal wildlife trade is the fourth-biggest criminal market on the planet — behind only narcotics, counterfeiting, and human trafficking. And like any criminal trade of that scale, there's a hugely sophisticated network behind it, moving billions.This week's episode was recorded in the media room at the United for Wildlife Business Forum in London, set up by the Royal Foundation.Our expert host, Marit Rødevand, is joined by Esteban Castaño, CEO and Co-Founder of TRM Labs, and Tricia Raxter, Director of Intelligence & Analysis at United for Wildlife, to ask: can following the money disrupt the illegal wildlife trade?The panel discuss: how this trade moves through the financial system, how crypto and online marketplaces have supercharged the industry, and what tools can help us fight back.Producer: Matthew Dunne-MilesEditor: Dominic DelargyCheck out our new short-film Yes, Chef! here. Subscribe to our newsletter, Fresh Laundry, here.____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.ai Hosted on Acast. See acast.com/privacy for more information.

Onchain analytics splits into two buckets: Research & Reporting (Dune dashboards, DeFi volume, DAO treasuries) and Risk & Compliance, which layers on attribution (naming wallet clusters) and risk scoring (sanctions, AML exposure) using tools like Chainalysis, TRM Labs, and Elliptic.This episode focuses on the Risk & Compliance side with Leopoldt Jansen Van Vuuren, Head of Onchain Analytics at Provenance, a compliance firm serving 400+ clients across 18 jurisdictions in VASPs, crypto funds, tokenised offerings, and DAOs.✅ OUR RESOURCES

What's up fraud fighters, and welcome back to Fraud Forward!In this episode, I'm sitting down with Mudassar Malik, Special Agent with the U.S. Secret Service and Founder and CEO of Deconflict.com, to talk about something our industry needs to get a whole lot better at: financial crime deconflict.Money mule networks do not care where one institution's visibility ends and another one begins. Pig butchering scams, romance scams, business email compromise, BEC fraud, account takeover, wire fraud, they all move across people, accounts, institutions, platforms, and jurisdictions. Meanwhile, too many of us are still trying to solve pieces of the same case from opposite sides of the wall.Mudassar walks us through what happens when law enforcement and banking actually have a better way to connect investigative intelligence, share what they are seeing, and recognize when different teams may be looking at the same financial crime pattern from different angles.This episode is not about sharing everything with everybody. It is about better fraud response, better financial crime intelligence, and better collaboration between the people who are already fighting the same criminal networks. Because if a credit union, a community bank, a larger institution, and law enforcement are all seeing pieces of the same mule activity, but nobody can connect those pieces fast enough, the criminals keep moving. And the victims keep paying for it. What you'll hear in this episode: Why financial crime deconflict matters for banks, credit unions, fintechs, and law enforcementHow the Deconflict platform helps connect investigative intelligence across financial crime casesWhy money mule networks, pig butchering scams, romance scams, and BEC fraud require cross-institutional visibilityWhere 314(b)d information sharing fits into the larger fraud response conversationWhy financial institution fraud prevention cannot stop at the edge of one institution's dataHow law enforcement data sharing can help fraud fighters move from isolated cases to connected intelligenceWhat teams can take back to think differently about collaboration and case escalation You should listen to this episode if you:Work in fraud, BSA, AML, investigations, or financial crime intelligence at a bank or credit unionAre trying to improve financial institution fraud prevention without adding more disconnected alertsSupport fraud response for scams, mule activity, business email compromise, or suspicious account movementWant a better way to think about law enforcement data sharing and investigative collaboration

Dimitri Masin was one of the first 30 employees at Monzo, where he led AI and data science as the bank grew from 30 to 4,000 people. That vantage point showed him where the real work in financial services still lives: the manual, repetitive customer operations running behind the app. In 2023, he co-founded Gradient Labs to automate that work with fully autonomous AI agents, and the company now serves more than 30 fintech and financial services customers. In this conversation, we get into why co-pilots can quietly degrade quality and compliance, why Dimitri believes full autonomy is the safer path, and the story behind what may be the largest known AI agent deployment in banking.What We CoveredFrom Google to one of the first 30 people at MonzoThe second half of the fintech transformationWhy customer operations never got reinventedWhat GPT-4 unlocked at the start of 2023Putting banks on autopilotSitting as an orchestration layer over existing systemsThe 15% customer experience uplift over human teamsWhy cost savings are more nuanced than people expectHow bank implementations and bake-offs actually workWhy co-pilots can degrade quality and complianceThe case for full autonomy over a human in the loopBenchmarking agents against the human team, not perfectionRedeploying staff instead of cutting headcountThe largest known AI agent deployment in bankingWhy banks aren't seeing productivity gains yetThe build-it-ourselves mindset shiftA five to ten year view of the transformationHow the US bake-off culture plays to a specialist's advantageKey TakeawaysThe overlooked opportunity in banking is not the app experience but the manual operational work behind it: customer support, AML, fraud, KYC, onboarding, and screening.Co-pilots can backfire. When suggestions are right 90% of the time, people start accepting them blindly, which degrades quality and compliance in the other 10%.No agent is correct 100% of the time, and that is the wrong bar. The right question is whether the system beats the human team it replaces, which becomes the benchmark.Automation has not meant layoffs at any of Gradient Labs' customers. Teams get redeployed to complex, higher-empathy work like vulnerability and financial difficulty cases.The bottleneck on transformation is not the technology, which has existed since GPT-4, but how slowly organizations diffuse and adopt it. Dimitri's horizon is five to ten years.About Dimitri MasinDimitri Masin is the CEO and co-founder of Gradient Labs, a London-based startup building autonomous AI agents that run customer operations for regulated financial services companies. Before founding the company in 2023 with two former Monzo colleagues, he was among the first 30 employees at Monzo, where he led AI, data science, financial crime, and fraud as the bank scaled to roughly 4,000 people. He started his career at Google.Connect with Fintech One-on-One:Tweet me @PeterRentonConnect with me on LinkedInFind previous Fintech One-on-One episodes

What does compliance look like when payments regulation, crypto licensing, and AML requirements are all changing at the same time?In the latest episode of Compliance Champions, Delphine Forma sits down with Hailey Shi, Legal Counsel at Manova, for a deep dive into Australia's rapidly evolving regulatory landscape and what it means for payment service providers, crypto businesses, and compliance professionals.They cover:• Australia's transition to a new function-based payments licensing framework • how the digital asset licensing regime will impact exchanges, broker dealers, custodians, and assets tokenization platforms • the implications of bringing crypto businesses into a broader financial services framework • the shift from prescriptive AML rules to risk-based compliance obligations • travel rule implementation challenges for payment providers and digital asset businesses • the introduction of reporting groups and lead entities under Australia's AML reforms • practical strategies for operationalizing major regulatory change across legal, compliance, product, and engineering teams • where AI can improve compliance efficiency and support regulatory implementation effortsHailey shares practical lessons from the front lines of regulatory transformation, offering valuable insights into licensing, financial crime compliance, governance, payments infrastructure, and digital asset regulation.A must-listen episode for professionals working in compliance, legal, financial crime, payments, fintech, and cryptocurrency regulation.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Heinz Zoller and Raul Ribeiro on their latest articles published in Blood. Dr. Zoller discusses "Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia", and how these findings support consideration of alternative IV iron formulations that provide similar efficacy without risk of skeletal complications.  Dr. Ribeiro discusses "A low-versus standard-dose regimen an induction for AML: a multicenter, randomized noninferiority trial" and how the low-dose regimen is associated with fewer toxicities, faster hematologic recovery, and reduced health care costs, suggesting a feasible treatment strategy for resource-limited settings.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a wave of exciting advancements and strategic movements shaping the landscape of this ever-evolving industry. Starting with a significant breakthrough in cell therapy, the FDA has granted approval to Orca Bio's Tregzi, a novel treatment aimed at preventing graft-versus-host disease (GVHD) in blood cancer patients undergoing allogeneic transplants. This approval emphasizes the potential of regulatory T cells in mitigating the severe complications that often accompany such transplants. The success of Tregzi not only marks a pivotal moment for cell therapy but also heralds a new era in transplant medicine where cellular therapies can significantly improve patient outcomes by reducing GVHD incidence. In other strategic moves, Ipsen's acquisition of Memo Therapeutics for up to $796 million highlights the industry's focus on addressing unmet needs in transplant medicine. Memo's work on monoclonal antibodies targeting the BK virus—a significant threat to kidney transplant patients—reflects a growing trend towards personalized medicine and targeted biologics. This acquisition is poised to bring much-needed therapeutic interventions to market, underscoring the sector's commitment to innovative solutions. Meanwhile, Anthropic is making waves with the introduction of Claude Science AI Workbench, accompanied by an internal drug discovery program aimed at neglected diseases. This initiative underscores the transformative role of artificial intelligence in drug discovery, particularly in areas previously overlooked due to limited commercial incentives. By accelerating the identification and development of novel therapeutics, AI-driven platforms promise breakthroughs in treating rare and neglected diseases. In clinical trial news, Abivax has reported promising Phase 3 safety data for obefazimod, a miR-124 enhancer targeting ulcerative colitis. By alleviating previous cancer-related concerns, obefazimod stands out as a potential small molecule oral therapy for autoimmune conditions. This advancement demonstrates ongoing innovation in small molecule therapeutics designed to modulate immune responses, expanding treatment options for ulcerative colitis patients. On the financial front, several companies are bolstering their pipelines through significant funding efforts. Alvotech has secured a $75 million term loan to enhance its biosimilar pipeline, reflecting the increasing importance of cost-effective biologic alternatives. AB Science has raised approximately $2.62 million focusing on oncology and rare diseases like acute myeloid leukemia (AML) and amyotrophic lateral sclerosis (ALS). Additionally, Flare Therapeutics' $85 million Series C round emphasizes precision medicine approaches targeting transcription factors, illustrating the industry's dedication to precision medicine. Regulatory landscapes are also shifting with Sarepta Therapeutics' FDA acceptance for full approval bids on Amondys 45 and Vyondys 53 despite confirmatory trial challenges. These therapies leverage exon skipping technology for Duchenne muscular dystrophy treatment, highlighting the intricate balance between accelerated approvals and robust clinical evidence requirements. In mergers and acquisitions news, Kimball Electronics' acquisition of Helvoet Polymer Technologies expands their drug delivery systems capabilities across Europe and India. This strategic alignment reflects broader industry trends towards integrated service offerings and global expansion efforts. Regulatory challenges continue with leadership changes at the FDA as Vijay Kumar steps down amid ongoing turbulence within gene and cell therapy sectors. Additionally, Angitia Biopharmaceuticals' termination of its Phase 3 trial for its BMP-6 candidate illustrates inherent risks and strategic pivots often necessary in drug development. Turning our focus globally, China's approval of its first CAR-T therapy for solid tumors signals a pivotal moment in oncology. This milestone could spur similar advancements worldwide, particularly drawing interest on when such treatments might receive approval in other regions like the United States. Moderna's expansion into in vivo CAR-T therapies for autoimmune diseases further marks a strategic divergence from traditional approaches, aiming to create off-the-shelf solutions that redefine treatment paradigms. Gene therapy continues to gain traction as Uniqure navigates regulatory reversals from the FDA regarding its Huntington's disease gene therapy filing for accelerated approval. This development hints at a broader shift within regulatory bodies towards fostering innovation in rare disease treatments under new leadership directives. Industry-wide trends also reveal a notable shift towards automation in cell therapy production led by companies like Cellares and Ori. This reflects growing demands for scalable manufacturing processes that enhance production capabilities while reducing costs. Overall, these developments illustrate a dynamic landscape where scientific innovations, strategic partnerships, regulatory adjustments, and technological integrations drive progress across various medical fields. As these sectors evolve, they hold vast potential for transforming patient care through groundbreaking therapeutic options and improved healthcare delivery systems worldwide.Support the show

According to Money20/20, the EMEA region accounts for 48% of the world's outbound cross-border payment flows — just under half!Now put yourself in the position of assessing those billions of transactions, moving at incredible speed, for financial crime risks and suspicious patterns. Sounds like a headache, right?Our expert host, Robin Lycka, is joined by René Hofer, CRO/CCO & Branch Director Germany at Holvi, to ask: "What keeps payments players up at night?" The pair discuss: the challenges facing compliance professionals in the payments industry, the solutions that could make a difference, and all the industry drama too.Producer: Matthew Dunne-MilesEditor: Dominic DelargyVideo: Loïs Dunford____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.aiSubscribe to our newsletter, Fresh Laundry, here.Check out our new short-film Yes, Chef! here. Hosted on Acast. See acast.com/privacy for more information.

What's up fraud fighters, and welcome back to Fraud Forward!Today we are talking about ACH compliance, and I know that may not sound like the most exciting opener in the world, but if you work in fraud, payments, operations, compliance, treasury, management, or anywhere near ACH this matters because ACH is one of the most widely used payment rails in the country. And when something goes wrong, it doesn't just stay contained to one team. It impacts customers, creates operational strain, introduces regulatory risk, and can expose gaps in how your institution detects and responds to fraud.Over the last few months, I have had conversation after conversation with fraud leaders at community banks and credit unions who are asking the same questions. Do we need new technology? Are we expected to monitor every ACH transaction in real time? What exactly are examiners going to expect from us? And if your head has been spinning a little bit, I want you to hear me on this: you are not alone. This episode is about the real story behind NACHA Phase 2. And to me, the real story is not that every institution needs to run out and buy another fraud platform. The real story is that ACH compliance is becoming a much more intentional conversation. It is about knowing your risk, documenting your processes, understanding who owns what, and being able to explain why your institution monitors ACH fraud the way that it does.I actually think that is a good thing. Because for too long, our industry has leaned on liability as the finish line. If we are not liable, it is not really our problem. And technically, maybe sometimes that has been true. But operationally, ethically, and from a fraud fighter perspective, that has never sat well with me.Fraud does not live in silos. Neither should ACH fraud prevention.What you'll hear in this episode:Why NACHA Phase 2 is about intentionality, not just technologyWhat changed in the final Nacha ACH rules and why that flexibility matters How ACH compliance applies to community banks and credit unions now in scopeWhy layered controls do not always mean buying another vendor solution How false pretenses fit into ACH fraud detection and ACH fraud prevention Why RDFI compliance and ODFI compliance require clear ownership across teamsWhat examiners may expect when reviewing your ACH compliance programFive questions every institution should ask about ACH fraud documentationYou should listen to this episode if:You work in fraud operations, payments compliance, ACH operations, BSA, AML, or treasury managementYour institution is working through NACHA Phase 2 implementationYou are trying to understand ACH examiner expectations without overbuilding your programYou serve a community bank or credit union and need practical ACH compliance guidanceYou want to move from a liability mindset to a visibility mindset in payments fraud If you liked this episode, be sure to subscribe and review the podcast on iTunes, Spotify, YouTube, or wherever you listen to podcasts.

Christopher Cogle joins the EMJ Podcast for a quickfire discussion on oncology, innovation, and public health policy. From personalised cancer care and AI in medicine to AML challenges and healthcare reform, he shares concise insights from across clinical medicine and policy leadership.

In this first deep dive, Christopher Cogle explores the evolving landscape of acute myeloid leukaemia (AML). He discusses the challenge of translating research into real-world outcomes, emerging immunotherapies, precision diagnostics, and how innovations such as the Acute Leukemia Methylome Atlas may reshape AML management in the future.  Timestamps:  00:55 – Research Gaps  03:50 – Biologics  05:46 – AML Atlas  09:15 – Immunotherapy 

What happens when a mentor gets more out of an accelerator than the founders do?Zak Morris joined the Fuel accelerator as a subject matter expert in AI — but quickly realized he was learning just as much as the companies he was advising. In this episode, Zak breaks down how working with startups across cybersecurity, AML, and healthcare sharpened his own thinking, why Bentonville's density of world-class talent is an underrated advantage, and how one early conversation with a founder led to a permanent board seat.Whether you're a founder, a seasoned professional sitting on the sidelines, or someone who's never thought of themselves as a mentor — this one's for you.

In today's episode, we spoke with Courtney D. DiNardo, MD, MSCE, a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center and an associate member of The University of Texas Graduate School of Biomedical Sciences in Houston.In our exclusive interview, Dr DiNardo discussed the May 2026 FDA approval of decitabine (Dacogen) and cedazuridine (Inqovi) plus venetoclax (Venclexta) in patients with newly diagnosed acute myeloid leukemia (AML). DiNardo outlined numerous important facets of the approval, including its effects on the treatment paradigm, which patients will benefit most, safety considerations with the regimen, and quality of life advantages that have been observed with the combination. Furthermore, she discussed how this approval fits into a larger shift for the AML treatment paradigm and how the AML research field can build upon the approval of this regimen.

How is regulation shaping the future of gaming across the US and Canada?Live from the SBC Summit Americas 2026 show floor, this SBC Media podcast brings together a panel of North American gaming experts to discuss the biggest regulatory and compliance challenges facing the industry today.The conversation covers fragmented state and provincial frameworks, prediction markets, sweepstakes, AML requirements, KYC, taxation, black market operators, player protection and the growing need for regulatory harmonisation across North America.In this episode:✅ Why North American gaming regulation is becoming more fragmented✅ The biggest compliance challenges for operators✅ How US states and Canadian provinces approach regulation differently✅ Why prediction markets are dominating regulatory conversations✅ The role of KYC, AML and player protection✅ How operators manage compliance across multiple jurisdictions✅ Why Alberta's upcoming market launch matters for Canada✅ The ongoing challenge of offshore and black market operators✅ Why regulation is key to moving players into safer legal markets✅ How the World Cup could expose gaps in the current systemAs new products continue to emerge and regulated operators compete with offshore alternatives, the panel asks a crucial question: how can North America create a safer, more effective and more competitive gaming market?

In this episode of This Week in AML, Elliot Berman and John Byrne break down key developments from the latest FATF plenary—highlighting a growing global emphasis on fraud, stronger public-private collaboration, and updated guidance on payment transparency and targeted sanctions. They also explore the Wolfsberg Group's refreshed framework for a truly effective risk-based approach, centered on proportionality, prioritization, and outcomes—not just compliance for compliance's sake. Back in the U.S., the conversation turns to the evolving regulatory landscape around stablecoins, including new proposed rules extending KYC and CIP requirements—and concerns about whether they go far enough to address illicit finance risks. It's a wide-ranging discussion that reinforces a central theme: effectiveness—not just effort—is becoming the defining standard in AML.

English: In this episode of Whistleblower of the Week, guest host, Rachel Demeuse, an intern with Kohn, Kohn & Colapinto, interviews William Bourdon. Bourdon is one of Europe's most prominent human rights attorneys, founder of Sherpa and PPLAAF, and the lawyer who successfully defended Antoine Deltour and Edward Snowden, reflects on four decades at the forefront of whistleblower defense. He assesses what Europe's legal arsenal actually offers those who dare to speak out.The conversation moves from law to philosophy, exploring the role of whistleblowers as sentinels of democracy, the deep cultural divide between Europe and the United States on financial rewards. It ends on a pressing note: Bourdon's sharp critique of FinCEN's proposed AML whistleblower regulations, which he sees as part of a broader assault on press freedom and dissent, and a dangerous signal to authoritarian regimes worldwide.French: Dans cet épisode de Whistleblower of the Week, William Bourdon, l'un des avocats de droits de l'homme les plus influents d'Europe, fondateur de Sherpa et de la PPLAAF, défenseur d'Antoine Deltour, Rui Pinto et Edward Snowden, revient sur quatre décennies passées à défendre ceux qui osent parler. De la loi Sapin II à la loi Wasermann, il évalue ce que l'arsenal juridique européen offre réellement aux lanceurs d'alerte.L'entretien s'élève ensuite du droit à la philosophie, explorant le rôle des lanceurs d'alerte comme sentinelles de la démocratie, le fossé culturel profond entre l'Europe et les États-Unis sur la récompense financière. Il se conclut sur une actualité brûlante : la critique acérée de Bourdon à l'égard de la nouvelle réglementation FinCEN, qu'il perçoit comme une attaque contre la liberté de la presse, et un signal dangereux envoyé aux régimes autoritaires du monde entier. Listen to the podcast on WNN or on Spotify, Apple Podcasts, or Amazon. Subscribe on your favorite platform!

What were you doing at seventeen? If you were getting into trouble, it might've been with your teacher or parents!How about uncovering money laundering and, in turn, being sanctioned by the Russian government for your discoveries?Our expert host, Marit Rødevand, is joined by Alexander Browder, founder of the Global Cryptocurrency Laundering Database, to ask: "What does it take to get sanctioned by Putin at 17?"The pair discuss: building the world's first open-source database of crypto laundering, a rouble-backed stablecoin allegedly funding Russia's war, and how you find out you've pissed off Putin.Producer: Matthew Dunne-MilesEditor: Dominic DelargyVideo: Loïs DunfordCheck out our new short-film Yes, Chef! here. ____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.aiSubscribe to our newsletter, Fresh Laundry, here. Hosted on Acast. See acast.com/privacy for more information.

In this urgent 15-minute conversation, Stephan speaks with Ricki Allardice, one of the leaders of the Property Rights Defense Group, about South Africa's Draft Capital Flow Management Regulations 2026 — the most serious threat to Bitcoin self-custody the country has seen.Ricki breaks down exactly what the draft rules would do to private keys, self-custody, and everyday Bitcoiners, where the process stands right now, and what the community can still do before the 30 June 2026 public comment deadline.Timestamps:(00:00) - Overview of the Regulation Against Self Custody(04:07) - Public Consultation Process (05:49) - Can it be challenged?(07:20) - It's About Capital Controls(08:02) - AML, Sanctions, FATF (10:46) - What does it mean for Bitcoiners in South Africa?(12:22) - Safety or Security concern here?(14:22) - Call to Action and Support for Legal DefenseLinks: Site: propertyrightsdefense.orgX: https://x.com/PRDG_ZA Donate: https://btcpay386617.lndyn.com/apps/4TcSxV6dNFYzb1DBDthPL89Tjz72/crowdfund?ref=propertyrightsdefense.org Stephan Livera links:Follow me on X: @stephanliveraSubscribe to the podcastSubscribe to Substack

Welcome back to the Fintech Takes podcast. I'm Alex Johnson, joined by Andrew DiMattina, Product Architect at Persona (and expert in all things fraud and compliance, especially AML compliance), to explore the changing state of compliance in the U.S. and around the globe. The expectation going into this administration was deregulation. What banks and fintech companies have discovered over the last 18 months is that deregulation isn't less risk; it's a transfer of risk. The checklist era was expensive but legible. This era is cheaper on paper and harder in practice, especially when it comes to fraud and compliance.  When rules stop telling you exactly what to do, "compliance" collapses back into its actual substance: Can you really tell who your customer is and stop the bad ones? We get into: Why most organizations are staying the course on compliance programs even as the federal floor recedes What the OCC's consent order against Community Federal Savings Bank reveals about when a fintech program grows faster than its controls Why getting a charter doesn't mean your risk profile matches your size What "know your agent" actually means when a bot might be transacting on behalf of a legitimate customer (and why it adds a new question to KYC) --- This episode is brought to you by Persona.  The best fintechs expand what's possible for users. Persona does that for fraud prevention. Their recently upgraded link analysis tool surfaces connections in real time, letting you spot deepfakes, identity farms, and fraud rings during onboarding and investigations.  They just published their Fraud Leader's Guide to Link Analysis, a practical look at today's top risk signals, automating decisions, and scaling link analysis for fraud prevention. Download it now: http://withpersona.com/ftt-fraud  --- Sign up for Alex's Fintech Takes newsletter for the latest insightful analysis on fintech trends, along with a heaping pile of pop culture references and copious footnotes. Every Monday and Thursday: https://workweek.com/brand/fintech-takes/ And for more exclusive insider content, don't forget to check out my YouTube page. Follow Alex:  YouTube: https://www.youtube.com/channel/UCJgfH47QEwbQmkQlz1V9rQA/videos LinkedIn: https://www.linkedin.com/in/alexhjohnson Twitter: https://www.twitter.com/AlexH_Johnson Follow Andrew: https://www.linkedin.com/in/andrew-dimattina-4a3b0414/

"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN®, nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 220: Oncologic Emergencies 101: Febrile Neutropenia and Sepsis Clinical Journal of Oncology Nursing articles:  Exploring Experiences of Bereaved Caregivers of Older Adult Patients With Acute Myeloid Leukemia Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Oncology Nursing Forum article: An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies ONS book: BMTCN® Certification Review Manual (second edition) ONS course: Psychosocial Dimensions of Cancer Care™  ONS Learning Libraries:  Survivorship Learning Library Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship Care Plan Huddle Card American Association of Colleges of Nursing End-of-Life Nursing Education Consortium (ELNEC) American Cancer Society: Living As a Myelodysplastic Syndrome Survivor American Society of Hematology Aplastic Anemia and MDS International Foundation: MDS Toolkit Blood Cancer United: Myelodysplastic Syndromes Family Caregiver Alliance HealthTree Foundation Inspire: MDS Support and Discussion Community Myelodysplastic Syndromes Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "When our higher-risk patients have disease-related progression, their [malignancy] can transform to AML. And we know this occurs in about one-third of our patients and is one of the most serious late effects. Even in lower-risk disease, we have this worsening marrow failure with or without increasing blast, where [patients] may have just started out with anemia, then they also develop neutropenia and thrombocytopenia. And as those counts worsen, we usually know that their disease is progressing." TS 2:47 "The golden rule is looking at the blood count but also looking at the patient and how they're doing over time. The backbone of MDS monitoring is the complete blood cell count with the differential. What you're looking for is trends over time. How many units of blood are they receiving, what threshold are you going to transfuse them at, and how many units of blood are they getting at a time? ... And then paying attention to the absolute neutrophil count for infection risk. [Another] really important piece of when you look at the differential with patients is seeing if they have any abnormal cell counts. Do they have circulating blasts? Are those monocytes going up? If you start to see blasts circulating or increasing monocytes, then their disease could be changing, even if they have low-risk disease." TS 15:58 "For lower-risk disease, we're paying more attention to their quality of life, how the patient's tolerating therapy, trying to help them stay safe over the long haul, and starting them on iron chelation if it matches that patient and they can have access to those drugs. ... For higher-risk disease, if the patient's goal is to be cured and not to progress to AML, you want to get them to transplant if that's [also] one of their goals. If they do evolve into AML, try and see what treatment matches best for them." TS 22:28 "You want to start early for patients who have febrile neutropenia—that's really important when a patient is an hour or two away from a center where they can get started on antibiotics. So, you have to think outside the box. What can we do to keep them safe? ... I know this group in Alaska that's in our advisory meetings and they try to facilitate transportation to Seattle. That's the closest academic center to them. Collaborating with telemedicine appointments, starting earlier, developing that strong relationship with patients, and contacting them between visits [can help patients living in rural areas]." TS 25:22 "I think the biggest [psychosocial challenge] I see is a lot of unmet anxiety and depression counseling. A lot of times, [patients are] losing their place in their family because they're the ones that need all the help now. Also, the uncertainty that goes along with the diagnosis. There is communication skills counseling, and End-of-Life Nursing Education Consortium (ELNEC) has a lot of training for communication skills and how to really talk to patients. Not that we take the place of a psychologist, but just being able to talk to somebody can go a long way. And if we can get training for that, we can help more patients." TS 31:15

This week on This Week in AML, Elliot Berman and John Byrne unpack major developments shaping the financial crime landscape. They discuss FinCEN's guidance expanding Section 314(b) information-sharing to include fraud and what it means for financial institutions. The conversation also covers new CFPB guidance on lending and immigration-related risks, increased IRS scrutiny of nonprofits, and enforcement actions from the UK and New Zealand. Plus, they explore growing concerns about the future of U.S. anti-financial crime leadership, the challenges of beneficial ownership transparency, and ongoing investigations tied to high-profile cases.

Australia's crypto Travel Rule starts on 1 July 2026, and it is already changing how Aussies move Bitcoin and other crypto off exchanges. In this episode, Peter breaks down what AUSTRAC's rule actually requires, why exchanges are adding extra verification, and what it could mean for withdrawals, deposits, cold storage, and financial privacy.The key point is not that every blockchain transaction suddenly has your name written on-chain. The rule applies to regulated businesses such as exchanges, banks, remittance providers, and other virtual asset service providers. But if you move assets between an exchange and a self-custody wallet, expect more friction as platforms collect and pass on payer, payee, and tracing information.Is this a sensible compliance step to reduce scams and money laundering, or does it push too far into personal financial privacy? This episode looks at both sides and asks where the line should be drawn.Key Takeaways:- Australia's crypto Travel Rule takes effect on 1 July 2026 and applies to regulated crypto platforms and other financial businesses.- Crypto exchanges may need to collect and pass on identifying information when customers transfer assets to another platform or wallet.- The rule can apply regardless of transfer size, meaning small and large transfers may face similar compliance checks.- Withdrawals to self-custody wallets may require proof of wallet control before an exchange approves the transfer.- The Travel Rule does not mean names are automatically stamped onto public blockchains for every transaction.- Pure self-custody and peer-to-peer activity sit outside the exchange workflow, but deposits and withdrawals through regulated platforms can still face friction.- The debate is between stronger anti-scam and anti-money-laundering controls versus the loss of practical financial privacy for everyday crypto users.- Australian crypto users should understand the rule before moving assets so they are not surprised by delays or extra verification.Links & References:- https://link.learncardano.io/Z6geXE- Reddit - Please wait for verification: https://link.learncardano.io/HWI7V0- x.com: https://link.learncardano.io/bbReRJ- https://link.learncardano.io/frorAV- Australians are Withdrawing Their Bitcoin Because of This Rule Change: https://link.learncardano.io/3Jhrha- Binance Australia Mandates Full User ID for All Crypto Transfers Starting July 1: https://link.learncardano.io/sY4Rrj- Travel Rule Australia: Everything You Need to Know | Swyftx - Cheap, Easy, Secure: https://link.learncardano.io/50r9d9Website: https://link.learncardano.io/bQ68RcX/Twitter: https://link.learncardano.io/3a1QtvDisclaimer: This content is for educational purposes only. Nothing constitutes financial advice.DISCLAIMER: This content is for informational and educational purposes only and is not financial, investment, or legal advice. I am not affiliated with, nor compensated by, the project discussed—no tokens, payments, or incentives received. I do not hold a stake in the project, including private or future allocations. All views are my own, based on public information. Always do your own research and consult a licensed advisor before investing. Crypto investments carry high risk, and past performance is no guarantee of future results. I am not responsible for any decisions you make based on this content.

In this episode, Blood editor Dr. Laura Michaelis interviews Drs. Nigel Russell and Uwe Platzbecker on their articles published in volume 147 issue 10 of Blood. Dr. Russell discuses "CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non–adverse-risk AML: the NCRI AML18 trial" where a large randomized trial demonstrated that DA-GO2 provided greater overall survival as compared to CPX-351, and that further studies should compare DA-GO2 to lower-intensity venetoclax-based regimens. Dr. Platzbecker shares insights from the first prospective study to evaluate the clinical impact of early therapeutic intervention for MRD in "Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial" demonstrating potential therapies for patients to achieve and maintain remission.

What do you think is keeping anti-financial crime professionals up at night?According to Nasdaq Verafin's latest Global Financial Crime Report, there's something more pressing than deepfakes or even AMLA.It's money launderers growing up, graduating, and acting more like Fortune 500 companies than criminals.Our expert host, Marit Rødevand, is joined by Kamlesh Harry, Principal Strategic Advisor of Fraud Solutions at Nasdaq Verafin, to ask: how do we combat the professionalisation of money laundering?The pair discuss: what these money laundering networks actually look like, the human cost underneath the corporate language, and how we fight back with collective intelligence, AI, and FRAML.Producer: Matthew Dunne-MilesEditor: Dominic DelargyCheck out our new short-film Yes, Chef! here. ____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.aiSubscribe to our newsletter, Fresh Laundry, here. Hosted on Acast. See acast.com/privacy for more information.

What's up, fraud fighters, and welcome to Fraud Forward.In this episode, I am sitting down with Eric Shen, inspector in charge of the criminal investigations group for the United States Postal Inspection Service, to talk about something I think way too many fraud teams overlook: USPIS financial crime.When financial crime escalates, most of us immediately think FBI, Secret Service, Homeland Security, or local law enforcement. And listen, those partners matter. But the Postal Inspection Service is one of the most powerful investigative partners in financial crime investigations, especially when mail theft, check fraud, mail fraud, bank fraud, identity theft, money laundering, or organized fraud networks are part of the picture.This conversation is about more than stolen mail or missing packages. It is about how physical infrastructure still connects to modern financial institution fraud, how fraud teams can build stronger law enforcement partnerships, and why collaboration has to happen before the big case hits your desk.Because behind every fraud case is a real person. A member. A customer. A family. A business. Someone whose trust, dignity, and financial stability may have been shaken in a way they will never forget.And we, fraud fighters, have a responsibility to do something about that.What you'll hear in this episode:A practical breakdown of how USPIS financial crime investigations workWhy the United States Postal Inspection Service matters to banks, credit unions, fintechs, and payments companiesHow mail theft connects to check fraud, mail fraud, identity theft, bank fraud, and money launderingWhy physical mail still matters, even in a digital fraud environmentHow organized fraud networks use stolen mail, altered checks, social media, and other channels to scale financial crimeWhat makes a strong fraud referral to law enforcementWhy relationship building matters before major fraud investigations happenHow IAFCI and other industry networks help financial crime investigators connect the dotsWhy criminals are using social media, Telegram, and other platforms to organize fraud activityHow AI and agentic AI are changing the future of financial crime investigationsWhy human oversight still matters when we use technology to fight fraudWho should listen:Fraud fighters at banks and credit unionsCommunity bank and credit union leadersBSA, AML, fraud, and compliance teamsFintech and payments risk teamsFinancial crime investigatorsFrontline teams who see suspicious activity before anyone else doesLaw enforcement partners working fraud investigations and financial crime casesRisk leaders trying to improve referral and escalation processesAnyone responsible for fraud prevention, investigation, intelligence sharing, or victim supportThis episode is for the teams who are trying to protect people in the middle of a fraud landscape that is moving fast.

In this month's Cayman Islands Regulatory 15/15 episode, Chris Capewell, Laura Goucke and Yunie Wong review industry consultations, new CRS 2.0 self-certifications and CIMA's 2026 annual AML return season.Still have questions about Common Reporting Standard 2.0, tokenised fund regulation or AML/CFT updates? Join our Lexology webinar on Thursday, 25 June for practical, expert-led insights from Chris Capewell, Patrick Head, Jo Ottaway and Lisa Page: https://lbresearch.zoom.us/webinar/register/7317782516165/WN_Z8FKXKFkQm2AlwoHQfSBgwTo read the 2026 Cayman Islands Regulatory Calendar, visit: https://maples.com/regulatory-round-up/2026-cayman-islands-regulatory-calendar.To read the 2026 BVI Regulatory Calendar, visit: https://isu.pub/MgRPtyFSPEAKERS:Chris Capewell, Partner | +1 345 814 5666 | chris.capewell@maples.com | View bioLaura Goucke, Associate | +1 345 938 5304 | laura.goucke@maples.com | View bioYunie Wong, Legal Manager | +852 9016 0076 | yunie.wong@maples.com | View bioThe contents of this podcast do not constitute legal advice and need to be taken as a general update only.Visit our Regulatory Round-Up Blog for the latest developments and insights in the regulatory landscape.RELATED SERVICES:Maples Group Regulatory and Financial Services AdvisoryWith a depth of experience across all regulated sectors, the Maples Group Regulatory and Financial Services team is positioned to address client needs and sensitivities. We have the largest dedicated Cayman Islands Regulatory and Financial Services team in the offshore market.Follow Us:LinkedIn: https://www.linkedin.com/company/maplesgroup/Instagram: https://www.instagram.com/maplesgroup/Twitter: https://twitter.com/maplesgroupFacebook: https://www.facebook.com/maplesgroup/Website: https://maples.com/podcasts/15-15Blog: https://maples.com/regulatory-round-up

This week on This Week in AML, Elliot Berman and John Byrne break down a wide range of developments shaping the financial crime landscape. They unpack a new joint advisory from FinCEN and federal banking agencies targeting risks tied to unauthorized labor and its implications for banks. The conversation then turns to escalating concerns about “debanking,” including controversy over blocked charitable donations and its implications for access to the financial system. The episode also dives into a congressional hearing on Chinese money laundering networks and how evolving typologies are challenging traditional approaches to tracking money. Plus, insights on prediction markets and potential manipulation, fraud trends tied to social media platforms, EU sanctions targeting crypto, and progress in combating antiquities trafficking.

In this episode of The Safe Bet Show, Martin Lycka is joined by one of Canada's most respected gaming industry experts, Troy Ross, President of TRM Public Affairs.The conversation explores the rapid evolution of Canada's regulated gaming market, including Alberta's upcoming iGaming launch, Ontario's continued success, responsible gambling initiatives, and why more provinces could soon follow the regulated model.Troy shares insights from more than three decades working across Canadian gaming regulation, public policy and industry affairs, offering a unique perspective on where the market is heading next.Topics include:

The episode “AI Integration Into Compliance” explains how artificial intelligence is already becoming a practical tool for bank compliance teams as regulatory expectations rise, data volumes grow, and manual compliance processes become harder to sustain. Dean highlights three major areas where AI is creating value: transaction monitoring and AML, where machine learning can reduce false positives and detect suspicious activity more effectively; regulatory change management, where AI can scan updates and map them to internal policies and controls; and risk assessments/reporting, where AI can aggregate data to give management and boards clearer insights. However, the episode emphasizes that AI is not a plug-and-play replacement for compliance professionals. Banks must maintain strong governance, transparency, explainability, data controls, model validation, documentation, human oversight, and clear escalation paths. The key message is that AI should support compliance judgment—not replace it—and institutions should start with low-risk, high-pain use cases, clean and govern their data, collaborate across departments, and be ready to explain their AI tools to regulators. Brought to you by GeoDataVision and M&M Consulting

What's up, fraud fighters, and welcome to Fraud Forward.I recorded this live from Safeguard's AI Deep Dive Retreat at The Broadmoor in Colorado Springs, and y'all, let me tell you something: this was not just another room full of AI buzzwords. This was fraud leaders, payment experts, financial institution professionals, fintech voices, marketplace operators, and risk leaders all sitting in the same place asking one very real question.What happens to fraud prevention when artificial intelligence changes everything?The future of AI fraud is not some far-off thing we are all fixin' to deal with later. It is already here. We are seeing AI change the speed, scale, and complexity of fraud operations right now. We are seeing it show up in synthetic identity fraud, AI scams, AI identity verification, agentic AI fraud, fraud detection automation, governance conversations, and the pressure fraud teams are already carrying every single day.But this episode is not about panic.It is about realism.It is about what fraud fighters are seeing, what institutions are building, where the gaps still are, and how we keep humans at the center while fraud keeps accelerating around us.What you'll hear in this episode:A practical conversation about the future of AI fraud and what it means for fraud operationsHow AI fraud prevention is changing across banking, credit unions, fintech, payments, marketplaces, and risk teamsWhy synthetic identity fraud, AI scams, and identity fraud prevention are becoming major areas of concernHow AI in fraud prevention can help investigators analyze data, identify patterns, and reduce noiseWhy AI governance in fraud prevention cannot be treated as something we clean up laterHow agentic AI fraud, know your agent, and KYA fraud prevention are becoming part of the next conversationWhy human-in-the-loop fraud detection still matters, even when fraud analyst AI tools are getting betterHow fraud fighters and AI can work together without replacing the people who know this work bestA reminder that responsible AI risk management has to include governance, empathy, collaboration, and practical controlsWho should listen:Financial institution leaders and fraud professionalsRisk, compliance, and cybersecurity teamsFraud operations teams and investigatorsCredit union and community bank leadersBanking fraud prevention teamsCredit union fraud prevention teamsFintech, payments, and marketplace risk teamsBSA, AML, KYC, and identity teamsRegulators and policy advisorsIndustry advocates and victim support professionalsMedia professionals covering scams, fraud, AI, and financial crimeAnyone trying to understand how AI-driven fraud affects real people, real institutions, and real fraud teamsThis conversation is for the fraud fighters who are not just trying to check a compliance box. It is for the teams trying to protect members, customers, and communities while also figuring out how to use AI-powered fraud prevention without creating new risk.

Industry experts estimate synthetic identity fraud costs the financial industry as high as $95 billion a year, and the most damaging attacks pass every verification check without triggering a single alert.Tedd Huff, CEO of fintech advisory firm Voalyre and founder of Fintech Confidential, brings 25 years of payments and fraud infrastructure experience to a direct conversation with Hal Lonas, Chief Technology Officer of Trulioo, the identity verification platform trusted by Google, JP Morgan Payments, Stripe, Airbnb, and Meta.Lonas explains why detection rates hide more than they reveal, how fraudsters now add intentional imperfections to AI-generated deepfakes to beat detection systems, and why agentic commerce requires an entirely new verification layer beyond KYC and KYB. The conversation covers Trulioo's Know Your Agent (KYA) framework, the Digital Agent Passport, Google's Agent Payments Protocol (AP2), and the privacy regulation debate most compliance teams have not fully worked through.Find out more1️⃣ Ask your identity vendor for their false negative rate, not just their detection rate, and demand specific numbers.2️⃣ Build continuous monitoring into your post-onboarding workflow so your system is still watching on day 30, 60, and 90.3️⃣ Audit every automated decision model in your stack and document the logic before your next regulatory exam.4️⃣ Map your verification flow and tier friction based on real-time risk signals instead of running flat checks on every customer.5️⃣ Get your compliance and growth teams in the same room with a shared dashboard showing fraud loss rates and abandonment rates side by side.Guest:Hal Lonas LinkedIn: https://www.linkedin.com/in/hal-lonas-4555b1Hal Lonas X: https://x.com/hal_lonasCompany:Trulioo: https://www.trulioo.comFintech Confidential:Podcast: https://fintechconfidential.com/listenNotifications: https://fintechconfidential.com/accessLinkedIn: https://www.linkedin.com/company/fintechconfidentialX: https://x.com/FTconfidentialInstagram: https://www.instagram.com/fintechconfidentialFacebook: https://www.facebook.com/fintechconfidentialSupporters:Under.io streamlines application and underwriting by digitizing PDFs for digital signature: under.io/FTCSkyflow is a zero trust data privacy vault delivered as an API, covering PCI, CCPA, GDPR, SOC 2, and beyond: skyflowsecure.comDFNS provides wallets as a service, API first, multi-chain, secured with MPC, used by Stripe, Fidelity, and others: fintechconfidential.com/dfnsHawk AI offers real-time payment screening, AML monitoring, and dynamic customer risk rating to reduce false positives: gethawk.comAbout:Hal Lonas is the Chief Technology Officer of Trulioo, where he leads technology strategy, product development, and engineering. He co-founded BrightCloud, a cloud-native threat intelligence company, and previously served as CTO at Webroot, Carbonite, and OpenText before joining Trulioo in 2021.Trulioo is a global identity verification platform operating across 195 countries, covering 14,000+ ID document types, 6,000+ watchlists, and 700 million business entities.Tedd Huff is CEO of Voalyre and founder of Fintech Confidential. The show is produced by DD3 Media and brings you the people, tech, and companies that change how you pay and get paid.Chapters: 00:00 Introduction01:28 Meet Trulioo CTO02:48 From Space to Security04:11 Dfns: Wallets as a Service (sponsor)05:32 Sleeper Accounts Explained08:33 False Negatives Metric11:43 Explainable Adaptive ML13:23 Deepfakes Raise Stakes15:03 Asymmetric Defense Signals17:51 Privacy Versus Safety21:25 Sky Flow: Building Fast and Secure (sponsor)22:27 Friction Based Risk24:16 Case Study ConsenSys26:04 Know Your Agent Future27:52 Agent Passport Checks32:43 Open Standards AP234:35 Are Defenders Losing36:05 Leader Advice Wrap40:37 Final Thoughts and Outro41:36 Hawk AI - Realtime Fraud Monitoring (sponsor)42:23 DisclaimerDisclaimer: The information provided in this episode is for informational purposes only and should not be considered financial, legal, or investment advice.#syntheticidentityfraud #identityverification #KYC #KYB #agenticcommerce #KnowYourAgent #deepfakedetection #fintechfraud #fraudprevention #AML #trulioo #AP2 #GoogleAP2 #AIfraud #fintechcompliance #fintechconfidential

In this episode of This Week in AML, John Byrne and Elliot Berman break down key developments shaping the financial crime and compliance landscape. The conversation opens with reflections on Federal Reserve independence following Chair Jerome Powell's recent remarks, before turning to U.S. policy updates and bipartisan actions with implications for governance and oversight. The discussion then shifts to practical compliance takeaways, including OFAC's newly released sanctions overview and a $1 million settlement highlighting how sanctions risks can arise through indirect client relationships. Internationally, the hosts examine Finland's national money‑laundering risk assessment, the evolving EU transparency rules on beneficial ownership, and growing concerns about human trafficking linked to major global sporting events. The episode also explores ongoing investigations into fintech and payments firms, emerging risks in cross‑border money movement, and a new Basel working paper on stablecoin liquidity and regulation.

In this episode of AML Conversations, John Byrne is joined by Sarah Beth Felix, author of Dirty Money Weekly, for an in-depth discussion on the biggest developments impacting financial crime compliance professionals. From recent OCC and FDIC consent orders to evolving executive orders shaping fintech and AML regulation, Sarah shares sharp, practical insights drawn from the front lines. The conversation highlights why “a clean audit is not a good audit,” the risks hidden in fintech-bank partnerships, and how even small institutions can fall into critical compliance gaps. Sarah also breaks down the real-world challenges posed by new policy directives—and why many may be harder to implement than they appear. The episode closes with a must-hear reminder for AML teams: focus on what truly matters—identifying and reporting suspicious activity that law enforcement can actually use. If you're not getting feedback on your SARs, it may be time to take a closer look at your program.

Today on Crypto Town Hall, the panel discusses Bitcoin's dip near $66k, breaking down Michael Saylor and MicroStrategy's recent Bitcoin sale, its market narrative impact, tax-loss harvesting strategies, Bitcoin-per-share growth, and concerns over reduced corporate buying power. They explore AI siphoning liquidity into IPOs and tech stocks, quantum risks, capital flows, and potential short-term downside to the $50-55k range. Additional topics include the Clarity Act, stablecoin regulation, AML and national security narratives, distressed digital asset treasuries, and Hyperliquid's emerging role in pre-IPO price discovery. Learn more about your ad choices. Visit megaphone.fm/adchoices

High‑risk MDS and AML continue to challenge clinicians, with limited durable responses and few options for older or treatment‑refractory patients. In this sponsored episode of The Top Line, host Stephanie Butler is joined by Dr. Amer Zeidan, Professor of Internal Medicine at Yale School of Medicine, to unpack new ASCO 2026 data that are drawing attention across the myeloid malignancies field.The discussion focuses on mesutoclax, a novel oral BCL‑2 inhibitor evaluated in combination with azacitidine. Dr. Zeidan breaks down early findings showing a 100% objective response rate with CR rate of 40% per IWG 2006 criteria and 90% composite complete response with CR in 60% in treatment‑naïve high‑risk MDS, along with strong efficacy and encouraging safety signals in AML, with over 80% composite CR, and with potent activity in TP53 mutant, as well as zero death within 30 or 60 days and rapid cytopenia recovery.Listeners will hear how mesutoclax’s potency, selectivity, and pharmacokinetic profile may overcome key limitations of existing BCL‑2 inhibitors, and what these results could mean for future frontline treatment strategies.See omnystudio.com/listener for privacy information.

What's up, fraud fighters, and welcome back to Fraud Forward!This conversation is one I think a lot of us need right now.Financial services are moving fast. Fintech innovations, AI in financial services, real-time payments, embedded finance, digital assets, and payment systems modernization are all changing how institutions serve members and customers.And let me just assure you, fraud fighters are not anti-innovation.We are not the department of no. We are the people who know what happens when fintech innovation moves faster than controls, when fintech compliance is treated like a checklist, and when fraud risk management gets discussed only after something has already gone wrong.In this episode, I sit down with Nyla Cortes to talk through what fintech innovations really mean for credit unions, community banks, fraud teams, BSA officers, compliance leaders, and frontline staff trying to protect people in real time.Because behind every fraud case is a customer. A member. A family. Someone whose trust, dignity, and financial stability may be permanently affected.That is why this conversation matters.What you'll hear in this episode:A practical look at how fintech innovations are changing fraud risk inside financial institutionsWhy modernization creates opportunity, but also expands the attack surfaceWhat AI governance in financial services needs to look like before something goes wrongHow AI in financial services can support fraud prevention strategies when governance is built inWhy real-time payments require real-time fraud operationsHow fintech partnerships and third-party risk management can introduce hidden exposureWhy fintech risk management has to include fraud, compliance, BSA, AML, operations, and frontline teamsWhat community bank fintech adoption looks like when resources are already stretchedWhy operational readiness matters before losses show up on a reportHow we can support fintech fraud prevention without forgetting the people impacted by crimeThis is not a political conversation. It is not a vendor pitch. It is a practical, honest conversation about what it takes to modernize responsibly.Who should listen:This episode is for the fraud fighters doing the work every day.Fraud directors and fraud analystsBSA and AML officersRisk and compliance leadersCommunity bank and credit union teamsFrontline tellers and member service representativesVendor risk and fintech partnership teamsCybersecurity and payments professionalsRegulators and policy advisorsAnyone trying to balance fintech innovation, fraud prevention strategies, consumer protection, and operational realityIf you are sitting inside a smaller institution thinking, “Holy moly, we are being asked to move faster, but we do not have the same resources as the big banks,” I want you to hear me.You are not behind because you are doing something wrong. You are operating in an environment where fintech innovations are accelerating faster than the resources available to manage the risk.And that means we have to get very intentional.Show Notes:https://www.whitehouse.gov/presidential-actions/2026/05/integrating-financial-technology-innovation-into-regulatory-frameworks/https://www.whitehouse.gov/fact-sheets/2026/05/fact-sheet-president-donald-j-trump-integrates-financial-technology-innovation-into-regulatory-frameworks/https://www.sardine.ai/whitepapers/the-agentic-ai-oversight-framework

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT

In this episode, Tom Fox welcomes Matt Ellis of Miller & Chevalier about the ACI “Cartels, TCOs and Compliance in Latin America” forum (July 20–21, Washington, DC) and why cartel/TCO/FTO risk is a timely 2026 compliance priority. Ellis describes the Trump administration's focus on cartels, fentanyl, China's influence, and the expanded enforcement toolkit—FCPA guidance linking to cartel activity, sanctions, AML actions (including FinCEN orders against Mexican financial institutions), and cartel FTO designations implicating the Anti-Terrorism Act. They discuss how cartels infiltrate supply chains, creating “material support” exposure, and why due diligence must go beyond traditional screening to on-the-ground intelligence and nuanced red flags. Ellis notes government interest in compliance expectations, extortion-payment considerations, the Lafarge/ISIS example, anticipated investigations, broader regional risk (Mexico, Venezuela, Colombia, Brazil), and increased multi-agency coordination and potential dialogue with U.S. authorities. Key highlights: Why This Conference Now Due Diligence Goes Deeper Extortion and Self-Reporting Beyond Mexico Regional Risks Whole-of-Government Focus When to Engage Government Resources: Cartels, TCOs and Compliance in Latin America, July 20-21 Matt Ellis on LinkedIn Tom Fox Instagram Facebook YouTube Twitter LinkedIn To learn about the intersection of Sherlock Holmes and the modern compliance professional, check out Tom's latest book, The Game is Afoot-What Sherlock Holmes Teaches About Risk, Ethics and Investigations on Amazon.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

What's up, fraud fighters, and welcome back to Fraud Forward!I want to take a moment and talk about something bigger than one scam trend, one crypto headline, or one fraud typology. We are talking about fraud as infrastructure.Because what we are seeing right now is not isolated activity. Organized fraud networks are operating like coordinated systems, connecting pig butchering scams, social engineering scams, mule accounts, crypto money laundering, fraud and AML gaps, and national security and financial crime concerns.And y'all, this matters because behind every case is a real person. Someone's retirement. Someone's trust. Someone's financial stability. Someone who was manipulated by a criminal network long before the money ever moved.What you'll hear in this episode:Why fraud as infrastructure changes how we need to think about financial crimeHow organized fraud networks are using scam infrastructure, mule accounts, and crypto money launderingWhy pig butchering scams and social engineering scams are not simple one-off casesWhere financial institutions are making progress in fraud prevention and scam preventionWhy fraud investigations need stronger collaboration across fraud, AML, cybercrime, and law enforcementHow public-private partnerships can help close the gaps criminals are exploitingWhat fraud fighters can take back to their teams as organized fraud becomes more connectedWho should listen:Financial institution leaders and fraud professionalsRisk, compliance, fraud and AML, and cybersecurity teamsBSA officers and fraud investigatorsRegulators and policy advisorsPublic-private partnership leadersVictim support and advocacy professionalsAnyone trying to understand how organized fraud impacts real peopleFraud does not live in silos, and neither should our solutions.

In this episode of the Oncology Brothers podcast, we dived deep into the complexities of relapsed refractory acute myeloid leukemia (AML) with expert guest Dr. Joshua Zeidner, Chief of Leukemia Research at the University of North Carolina. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: ⁠X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explore two challenging cases: Revumenib (menin inhibitor) demonstrated an overall response rate of ~63% in heavily pre-treated KMT2A rearrangement-positive AML patients based on the AUGMENT-101 study, with QTc prolongation and CYP3A4 drug interactions as key monitoring considerations. FLT3 inhibitors like gilteritinib and quizartinib play an important role in MRD-positive FLT3 ITD/NPM1-mutated AML post-transplant, with the MORPHO trial supporting gilteritinib as maintenance therapy.  Menin inhibitors may have a broader role in high-risk AML including NPM1-mutated disease, and re-evaluating mutational profiles at relapse is critical for optimal treatment selection.  Careful monitoring of side effect profiles, drug interactions, and MRD status is essential when navigating targeted therapy decisions in relapsed refractory AML. Throughout the episode, we discuss key practical points, including the importance of monitoring for QTc prolongation and the impact of drug interactions with CYP3A4 inhibitors. Tune in for an informative discussion that sheds light on the latest advancements in targeted therapies for AML and the evolving landscape of treatment options. Don't forget to like, subscribe, and check out our other episodes in the challenging case series, treatment algorithms, and conference highlights! #AcuteMyeloidLeukemia, #MeninInhibitor, #FLT3Inhibitor, #Hematology, #OncologyBrothers

The FDA has been a bunch of busy bees with new approvals: 1. Sonrotoclax, an exciting new BCL2 inhibitor approved for 3rd-line Mantle Cell Lymphoma 2. An all PO regimen of decitabine/cedazuridine + venetoclax is approved for AML. 3. Zenoctuzumab gets an FDA approval for cholangiocarcinoma with an efficacy patient population = 19 4. T-DXd is a good drug and continues to pile on FDA approvals 5. Adjuvant atezolizumab in bladder cancer is approved in conjunction with ctDNA serial monitoring to determine who gets treatment Check out the Oncology Insights Newsletter: www.kelleycpharmd.com/newsletter-oncopharm